Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress
- 19 February 2004
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 9 (5), 219-228
- https://doi.org/10.1016/s1359-6446(03)02988-x
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Dendritic polymer macromolecular carriers for drug deliveryCurrent Opinion in Chemical Biology, 2002
- Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid LeukemiaBioconjugate Chemistry, 2001
- TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitorsProceedings of the National Academy of Sciences, 2001
- Structure and design of polymeric surfactant-based drug delivery systemsJournal of Controlled Release, 2001
- Biodegradable polymeric nanoparticles as drug delivery devicesJournal of Controlled Release, 2001
- Targeting Folate Receptor with Folate Linked to Extremities of Poly(ethylene glycol)-Grafted Liposomes: In Vitro StudiesBioconjugate Chemistry, 1999
- Novel applications of liposomesTrends in Biotechnology, 1998
- Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.Proceedings of the National Academy of Sciences, 1991
- Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.Proceedings of the National Academy of Sciences, 1988